NCT07069049

Brief Summary

Prostate biopsy is the gold standard for the diagnosis of prostate cancer, and transperineal puncture is a common approach. It has the advantages of no bowel preparation and relative safety. At present, transperineal puncture is often performed under local anesthesia, but there are still clinical problems such as pain and anxiety for patients. Electroacupuncture is often used as an auxiliary means of local anesthesia in China, which has the advantages of analgesia and anti-anxiety. This study was conducted to evaluate the efficacy and safety of electroacupuncture combined with local anesthesia in transperineal needle biopsy.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
190

participants targeted

Target at P50-P75 for not_applicable prostate-cancer

Timeline
5mo left

Started Dec 2025

Shorter than P25 for not_applicable prostate-cancer

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Dec 2025Sep 2026

First Submitted

Initial submission to the registry

May 20, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 16, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

December 28, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 28, 2026

Last Updated

December 9, 2025

Status Verified

December 1, 2025

Enrollment Period

8 months

First QC Date

May 20, 2025

Last Update Submit

December 2, 2025

Conditions

Keywords

electroacupunctureProstate Needle biopsyProstate Cancer

Outcome Measures

Primary Outcomes (1)

  • The maximum pain level

    Use Numerical Rating Scale to Assess the maximum pain level during the operation,0-100mm,higher scores mean a worse outcome.

    The end of the operation

Secondary Outcomes (4)

  • Area under the curve for cumulative pain scores

    1h、6h、24h after completion of surgery

  • Visual Analogue Scale for anxiety

    At the beginning of operation and at the completion of operation

  • Incidence of rescue analgesia and total number of rescue analgesia

    At the completion of operation

  • Blood pressure

    At the completion of the operation and 20 min before the start of the operation

Study Arms (2)

electroacupunture

EXPERIMENTAL

In the EA group, on the basis of routine local lidocaine anesthesia, EA stimulation was performed 20min before the operation and the needles were retained until the completion of the operation. Sterile acupuncture needles (Huatuo brand, specification: 0.25mm\*40mm) were applied to Hegu (Li4), Neiguan (PC 6), Guanyuan (CV 4) and Sanyinjiao (SP 6) by twidling, rotating, lifting and thrusting for 30 seconds. After getting qi (a feeling of acid, numbness, weight and swelling), the electronic acupuncture instrument (SDZ-II type, Huatuo brand) was connected, and the continuous wave was 50HZ. The current intensity was 1-5mA (preferably as much as the patient could tolerate without pain). Acupuncture was performed by a fixed-practice acupuncturist with at least 5 years of experience. Acupuncturists were trained in acupoints and acupuncture manipulation before the trial, and intervention completion was recorded.

Other: electroacupuncture

Sham-electroacupunture

SHAM COMPARATOR

The intervention process of patients in the control group was the same as that of the experimental group, but the acupuncture site was located 3mm away from the acupoints of the experimental group, and the acupuncture method was shallow acupuncture, only 1-4mm through the skin. After the sham acupuncture, the lifting and thrusting twisling method was not performed to avoid qi gain. The needles were removed if the patient experienced any adverse events related to acupuncture. Sham acupuncture was performed by a fixed-practice acupuncturist with at least 5 years of experience. Acupuncturists were trained in sham acupoints and acupuncture manipulation before the trial, and intervention completion was recorded.

Other: Sham-electroacupunture

Interventions

Sterile acupuncture needles (Huatuo brand, specification: 0.25mm\*40mm) were applied to Hegu (Li4), Neiguan (PC 6), Guanyuan (CV 4) and Sanyinjiao (SP 6) by twidling, rotating, lifting and thrusting for 30 seconds. After getting qi (a feeling of acid, numbness, weight and swelling), the electronic acupuncture instrument (SDZ-II type, Huatuo brand) was connected, and the continuous wave was 50HZ. The current intensity was 1-5mA (preferably as much as the patient could tolerate without pain).

electroacupunture

Sham electroacupuncture was applied at the non-meridian and non-acupoint sites 3mm apart from the acupoints in the experimental group. The acupuncture method was shallow acupuncture, only 1-4mm through the skin.

Sham-electroacupunture

Eligibility Criteria

Age18 Years - 80 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- (1) To voluntarily participate in the study, I or his legal representative signed a written informed consent.
  • (2) 18-80 years old (including 18 and 80 years old), male. (3) in accordance with the indication of prostate biopsy.

You may not qualify if:

  • (1) in the stage of acute genitourinary infection or fever. (2) patients with chronic pain (such as bone metastasis of prostate cancer, knee osteoarthritis, scapulohumeral periarthritis, etc.) or acute pain (tonsillitis, acute lumbar sprain, etc.) before surgery.
  • (3) Continuous use of anti-anxiety or analgesic drugs (use of anti-anxiety drugs or analgesics for more than 1 week in the past 3 months).
  • (4) in the decompensated stage of cardiac insufficiency; A disease with a tendency to bleed heavily.
  • (5) severe immunosuppression. (6) hypertension, diabetes and other complications were poorly controlled or unstable.
  • (7) complicated with severe internal or external hemorrhoids, perianal or rectal lesions, and anal stenosis.
  • (8) perineal skin ulceration, infection, and abnormal skin sensation. (9) patients with serious psychological diseases or uncooperative puncture. (10) allergy to narcotic drugs and fear of acupuncture operators. (11) Participants who participated in other clinical trials within 3 months before enrollment.
  • (12) other conditions considered by the investigator to be inappropriate to participate in the trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Prostatic Neoplasms

Interventions

Electroacupuncture

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Combined Modality TherapyTherapeuticsAcupuncture TherapyComplementary TherapiesElectric Stimulation TherapyPhysical Therapy ModalitiesRehabilitationTranscutaneous Electric Nerve StimulationAnalgesiaAnesthesia and AnalgesiaAnesthesia

Study Officials

  • Zhan Xiangyang

    Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physician in Charge

Study Record Dates

First Submitted

May 20, 2025

First Posted

July 16, 2025

Study Start

December 28, 2025

Primary Completion (Estimated)

August 28, 2026

Study Completion (Estimated)

September 28, 2026

Last Updated

December 9, 2025

Record last verified: 2025-12